Moran E - Search Results

1

Sophisticated Clean Air Strategies Required to Mitigate Against Particulate Organic Pollution.

Grigas T, Ovadnevaite J, Ceburnis D, Moran E, McGovern FM, Jennings SG, O'Dowd C. Grigas T, et al. Among authors: moran e. Sci Rep. 2017 Mar 17;7:44737. doi: 10.1038/srep44737. Sci Rep. 2017. PMID: 28303958 Free PMC article.

2

The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds.

Egan D, O'Kennedy R, Moran E, Cox D, Prosser E, Thornes RD. Egan D, et al. Among authors: moran e. Drug Metab Rev. 1990;22(5):503-29. doi: 10.3109/03602539008991449. Drug Metab Rev. 1990. PMID: 2078993 Review. No abstract available.

3

A critical analysis of the use of sialic acid determination in the diagnosis of malignancy.

O'Kennedy R, Berns G, Moran E, Smyth H, Carroll K, Thornes RD, O'Brien A, Fennelly J, Butler M. O'Kennedy R, et al. Among authors: moran e. Cancer Lett. 1991 Jun 14;58(1-2):91-100. doi: 10.1016/0304-3835(91)90029-h. Cancer Lett. 1991. PMID: 2049789

4

Analysis of coumarin and its urinary metabolites by high-performance liquid chromatography.

Moran E, O'Kennedy R, Thornes RD. Moran E, et al. J Chromatogr. 1987 Apr 24;416(1):165-9. doi: 10.1016/0378-4347(87)80499-1. J Chromatogr. 1987. PMID: 3597634 No abstract available.

5

A new monoclonal antibody, P2A8(6), that specifically recognizes a novel epitope on the multidrug resistance-associated protein 1 (MRP1), but not on MRP2 nor MRP3.

Connolly L, Moran E, Larkin A, Scheffer G, Scheper R, Sarkadi B, Kool M, Clynes M. Connolly L, et al. Among authors: moran e. Hybrid Hybridomics. 2001;20(5-6):333-41. doi: 10.1089/15368590152740734. Hybrid Hybridomics. 2001. PMID: 11839251

6

A new monoclonal antibody that specifically recognises the MDR-3-encoded gene product.

Larkin A, Moran E, Alexander D, Doherty G, Connolly L, Kennedy SM, Clynes M. Larkin A, et al. Among authors: moran e. Int J Cancer. 1999 Jan 18;80(2):265-71. doi: 10.1002/(sici)1097-0215(19990118)80:2<265::aid-ijc16>3.0.co;2-#. Int J Cancer. 1999. PMID: 9935209

7

Monoclonal antibody 5C3 raised against formalin fixed paraffin-embedded invasive breast tumour tissue: characterisation of its reactive antigen via immunoprecipitation and internal sequencing.

Larkin A, Moran E, Kennedy SM, Clynes M. Larkin A, et al. Among authors: moran e. J Immunol Methods. 2005 Aug;303(1-2):53-65. doi: 10.1016/j.jim.2005.05.011. J Immunol Methods. 2005. PMID: 16038928

8

Preliminary studies of a monoclonal antibody raised to the over expressed plasma membrane associated glycoprotein of a multidrug resistant cell line.

Moran E, Redmond A, Clynes M. Moran E, et al. Biochem Soc Trans. 1992 Feb;20(1):58S. doi: 10.1042/bst020058s. Biochem Soc Trans. 1992. PMID: 1353037 No abstract available.

9

Multiple drug resistance in the human ovarian carcinoma cell line OAW42-A.

Redmond A, Moran E, Clynes M. Redmond A, et al. Among authors: moran e. Eur J Cancer. 1993;29A(8):1078-81. doi: 10.1016/s0959-8049(05)80291-6. Eur J Cancer. 1993. PMID: 8100138

10

Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42.

Moran E, Cleary I, Larkin AM, Amhlaoibh RN, Masterson A, Scheper RJ, Izquierdo MA, Center M, O'Sullivan F, Clynes M. Moran E, et al. Eur J Cancer. 1997 Apr;33(4):652-60. doi: 10.1016/s0959-8049(96)00501-1. Eur J Cancer. 1997. PMID: 9274450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

806 results

Search Page

Filters